nodes	percent_of_prediction	percent_of_DWPC	metapath
Metixene—HTR2C—choroid plexus—malignant glioma	0.279	0.431	CbGeAlD
Metixene—HTR2C—telencephalic ventricle—malignant glioma	0.0816	0.126	CbGeAlD
Metixene—HTR2C—brainstem—malignant glioma	0.0221	0.0342	CbGeAlD
Metixene—CHRM4—central nervous system—malignant glioma	0.0215	0.0334	CbGeAlD
Metixene—CHRM2—telencephalon—malignant glioma	0.0203	0.0315	CbGeAlD
Metixene—HTR2C—telencephalon—malignant glioma	0.0196	0.0303	CbGeAlD
Metixene—CHRM1—telencephalon—malignant glioma	0.0185	0.0287	CbGeAlD
Metixene—CHRM4—brain—malignant glioma	0.0171	0.0265	CbGeAlD
Metixene—CHRM5—central nervous system—malignant glioma	0.0168	0.0261	CbGeAlD
Metixene—CHRM3—telencephalon—malignant glioma	0.0166	0.0256	CbGeAlD
Metixene—HTR2C—medulla oblongata—malignant glioma	0.0154	0.0238	CbGeAlD
Metixene—HTR2C—midbrain—malignant glioma	0.0141	0.0218	CbGeAlD
Metixene—HTR2C—spinal cord—malignant glioma	0.0137	0.0213	CbGeAlD
Metixene—CHRM5—brain—malignant glioma	0.0134	0.0207	CbGeAlD
Metixene—CHRM2—central nervous system—malignant glioma	0.0116	0.0179	CbGeAlD
Metixene—HTR2C—central nervous system—malignant glioma	0.0111	0.0172	CbGeAlD
Metixene—Diphenylpyraline—SLC6A3—malignant glioma	0.011	0.218	CrCbGaD
Metixene—CHRM1—central nervous system—malignant glioma	0.0105	0.0163	CbGeAlD
Metixene—CHRM3—central nervous system—malignant glioma	0.00942	0.0146	CbGeAlD
Metixene—CHRM2—brain—malignant glioma	0.00918	0.0142	CbGeAlD
Metixene—HTR2C—brain—malignant glioma	0.00885	0.0137	CbGeAlD
Metixene—CHRM1—brain—malignant glioma	0.00835	0.0129	CbGeAlD
Metixene—Ethopropazine—BCHE—malignant glioma	0.00798	0.159	CrCbGaD
Metixene—Maprotiline—SLC6A3—malignant glioma	0.00781	0.155	CrCbGaD
Metixene—CHRM3—brain—malignant glioma	0.00748	0.0116	CbGeAlD
Metixene—Mirtazapine—SLC6A3—malignant glioma	0.00714	0.142	CrCbGaD
Metixene—Mianserin—CYP2B6—malignant glioma	0.00616	0.122	CrCbGaD
Metixene—Mianserin—SLC6A3—malignant glioma	0.00525	0.104	CrCbGaD
Metixene—Promethazine—CYP2B6—malignant glioma	0.00499	0.0992	CrCbGaD
Metixene—HTR2C—Signaling Pathways—PDGFB—malignant glioma	9.89e-05	0.000326	CbGpPWpGaD
Metixene—CHRM2—Signaling Pathways—HES1—malignant glioma	9.86e-05	0.000325	CbGpPWpGaD
Metixene—CHRM5—Signaling Pathways—BRAF—malignant glioma	9.85e-05	0.000324	CbGpPWpGaD
Metixene—HTR2C—Signaling Pathways—FGFR1—malignant glioma	9.84e-05	0.000324	CbGpPWpGaD
Metixene—CHRM2—Signaling Pathways—NCOR1—malignant glioma	9.8e-05	0.000323	CbGpPWpGaD
Metixene—CHRM1—Signaling by GPCR—RAF1—malignant glioma	9.8e-05	0.000323	CbGpPWpGaD
Metixene—CHRM3—Signaling by GPCR—RAF1—malignant glioma	9.77e-05	0.000322	CbGpPWpGaD
Metixene—HTR2C—Signaling Pathways—HIF1A—malignant glioma	9.69e-05	0.000319	CbGpPWpGaD
Metixene—CHRM1—GPCR downstream signaling—IL2—malignant glioma	9.67e-05	0.000319	CbGpPWpGaD
Metixene—CHRM2—Signaling by GPCR—RAF1—malignant glioma	9.67e-05	0.000318	CbGpPWpGaD
Metixene—CHRM3—Metabolism—CAV1—malignant glioma	9.65e-05	0.000318	CbGpPWpGaD
Metixene—CHRM3—GPCR downstream signaling—IL2—malignant glioma	9.64e-05	0.000317	CbGpPWpGaD
Metixene—CHRM4—Signaling Pathways—PIK3CD—malignant glioma	9.62e-05	0.000317	CbGpPWpGaD
Metixene—CHRM5—Signaling Pathways—AKT2—malignant glioma	9.58e-05	0.000316	CbGpPWpGaD
Metixene—CHRM1—Signaling by GPCR—PIK3CB—malignant glioma	9.57e-05	0.000315	CbGpPWpGaD
Metixene—CHRM2—GPCR downstream signaling—IL2—malignant glioma	9.55e-05	0.000314	CbGpPWpGaD
Metixene—CHRM5—Signaling by GPCR—EGFR—malignant glioma	9.54e-05	0.000314	CbGpPWpGaD
Metixene—CHRM3—Signaling by GPCR—PIK3CB—malignant glioma	9.54e-05	0.000314	CbGpPWpGaD
Metixene—CHRM4—GPCR downstream signaling—PIK3CA—malignant glioma	9.52e-05	0.000314	CbGpPWpGaD
Metixene—CHRM1—Signaling Pathways—PDGFRA—malignant glioma	9.51e-05	0.000313	CbGpPWpGaD
Metixene—CHRM3—Signaling Pathways—PDGFRA—malignant glioma	9.48e-05	0.000312	CbGpPWpGaD
Metixene—CHRM2—Signaling by GPCR—PIK3CB—malignant glioma	9.44e-05	0.000311	CbGpPWpGaD
Metixene—CHRM4—Signaling by GPCR—KRAS—malignant glioma	9.41e-05	0.00031	CbGpPWpGaD
Metixene—CHRM2—Signaling Pathways—PDGFRA—malignant glioma	9.39e-05	0.000309	CbGpPWpGaD
Metixene—HTR2C—Signaling Pathways—CAV1—malignant glioma	9.37e-05	0.000309	CbGpPWpGaD
Metixene—HTR2C—Signaling Pathways—KDR—malignant glioma	9.27e-05	0.000305	CbGpPWpGaD
Metixene—CHRM1—Signaling Pathways—SPP1—malignant glioma	9.23e-05	0.000304	CbGpPWpGaD
Metixene—CHRM5—Signaling Pathways—PIK3CD—malignant glioma	9.21e-05	0.000303	CbGpPWpGaD
Metixene—CHRM4—Signaling Pathways—FGF2—malignant glioma	9.21e-05	0.000303	CbGpPWpGaD
Metixene—CHRM3—Signaling Pathways—SPP1—malignant glioma	9.2e-05	0.000303	CbGpPWpGaD
Metixene—CHRM1—Signaling by GPCR—CXCL8—malignant glioma	9.19e-05	0.000303	CbGpPWpGaD
Metixene—CHRM3—Signaling by GPCR—CXCL8—malignant glioma	9.16e-05	0.000302	CbGpPWpGaD
Metixene—CHRM5—GPCR downstream signaling—PIK3CA—malignant glioma	9.12e-05	0.0003	CbGpPWpGaD
Metixene—CHRM2—Signaling Pathways—SPP1—malignant glioma	9.12e-05	0.0003	CbGpPWpGaD
Metixene—CHRM2—Signaling by GPCR—CXCL8—malignant glioma	9.07e-05	0.000299	CbGpPWpGaD
Metixene—CHRM5—Signaling by GPCR—KRAS—malignant glioma	9.02e-05	0.000297	CbGpPWpGaD
Metixene—HTR2C—Signaling Pathways—FN1—malignant glioma	8.92e-05	0.000294	CbGpPWpGaD
Metixene—HTR2C—Signaling Pathways—F2—malignant glioma	8.92e-05	0.000294	CbGpPWpGaD
Metixene—HTR2C—Signaling Pathways—BAD—malignant glioma	8.82e-05	0.00029	CbGpPWpGaD
Metixene—CHRM5—Signaling Pathways—FGF2—malignant glioma	8.82e-05	0.00029	CbGpPWpGaD
Metixene—CHRM3—Metabolism—PIK3CG—malignant glioma	8.79e-05	0.000289	CbGpPWpGaD
Metixene—CHRM1—Signaling by GPCR—IL2—malignant glioma	8.79e-05	0.000289	CbGpPWpGaD
Metixene—CHRM3—Signaling by GPCR—IL2—malignant glioma	8.76e-05	0.000288	CbGpPWpGaD
Metixene—CHRM1—Signaling Pathways—TERT—malignant glioma	8.75e-05	0.000288	CbGpPWpGaD
Metixene—HTR2C—Signaling Pathways—NOTCH1—malignant glioma	8.73e-05	0.000287	CbGpPWpGaD
Metixene—CHRM3—Signaling Pathways—TERT—malignant glioma	8.73e-05	0.000287	CbGpPWpGaD
Metixene—CHRM2—Signaling by GPCR—IL2—malignant glioma	8.67e-05	0.000286	CbGpPWpGaD
Metixene—CHRM4—Signaling by GPCR—PIK3CA—malignant glioma	8.65e-05	0.000285	CbGpPWpGaD
Metixene—CHRM2—Signaling Pathways—TERT—malignant glioma	8.64e-05	0.000284	CbGpPWpGaD
Metixene—CHRM4—Signaling Pathways—MDM2—malignant glioma	8.61e-05	0.000284	CbGpPWpGaD
Metixene—CHRM4—Signaling Pathways—RAF1—malignant glioma	8.58e-05	0.000283	CbGpPWpGaD
Metixene—HTR2C—Signaling Pathways—CD80—malignant glioma	8.55e-05	0.000282	CbGpPWpGaD
Metixene—CHRM1—Signaling Pathways—PDGFB—malignant glioma	8.54e-05	0.000281	CbGpPWpGaD
Metixene—HTR2C—Signaling Pathways—APC—malignant glioma	8.54e-05	0.000281	CbGpPWpGaD
Metixene—HTR2C—Signaling Pathways—PIK3CG—malignant glioma	8.54e-05	0.000281	CbGpPWpGaD
Metixene—CHRM3—Signaling Pathways—PDGFB—malignant glioma	8.52e-05	0.00028	CbGpPWpGaD
Metixene—CHRM1—Signaling Pathways—FGFR1—malignant glioma	8.5e-05	0.00028	CbGpPWpGaD
Metixene—CHRM4—Signaling Pathways—ERBB2—malignant glioma	8.49e-05	0.00028	CbGpPWpGaD
Metixene—CHRM3—Metabolism—PPARG—malignant glioma	8.49e-05	0.000279	CbGpPWpGaD
Metixene—CHRM3—Signaling Pathways—FGFR1—malignant glioma	8.47e-05	0.000279	CbGpPWpGaD
Metixene—HTR2C—Signaling Pathways—EGF—malignant glioma	8.44e-05	0.000278	CbGpPWpGaD
Metixene—CHRM2—Signaling Pathways—PDGFB—malignant glioma	8.43e-05	0.000278	CbGpPWpGaD
Metixene—CHRM2—Signaling Pathways—FGFR1—malignant glioma	8.39e-05	0.000276	CbGpPWpGaD
Metixene—HTR2C—Signaling Pathways—PTPN11—malignant glioma	8.39e-05	0.000276	CbGpPWpGaD
Metixene—CHRM4—Signaling Pathways—PIK3CB—malignant glioma	8.38e-05	0.000276	CbGpPWpGaD
Metixene—CHRM1—Signaling Pathways—HIF1A—malignant glioma	8.37e-05	0.000276	CbGpPWpGaD
Metixene—CHRM3—Signaling Pathways—HIF1A—malignant glioma	8.34e-05	0.000275	CbGpPWpGaD
Metixene—CHRM5—Signaling by GPCR—PIK3CA—malignant glioma	8.28e-05	0.000273	CbGpPWpGaD
Metixene—CHRM2—Signaling Pathways—HIF1A—malignant glioma	8.26e-05	0.000272	CbGpPWpGaD
Metixene—CHRM5—Signaling Pathways—MDM2—malignant glioma	8.25e-05	0.000272	CbGpPWpGaD
Metixene—CHRM5—Signaling Pathways—RAF1—malignant glioma	8.22e-05	0.000271	CbGpPWpGaD
Metixene—CHRM5—Signaling Pathways—ERBB2—malignant glioma	8.13e-05	0.000268	CbGpPWpGaD
Metixene—CHRM1—Signaling Pathways—CAV1—malignant glioma	8.1e-05	0.000267	CbGpPWpGaD
Metixene—CHRM3—Signaling Pathways—CAV1—malignant glioma	8.07e-05	0.000266	CbGpPWpGaD
Metixene—CHRM4—Signaling Pathways—CXCL8—malignant glioma	8.05e-05	0.000265	CbGpPWpGaD
Metixene—HTR2C—Signaling Pathways—BRAF—malignant glioma	8.03e-05	0.000264	CbGpPWpGaD
Metixene—CHRM5—Signaling Pathways—PIK3CB—malignant glioma	8.03e-05	0.000264	CbGpPWpGaD
Metixene—CHRM1—Signaling Pathways—KDR—malignant glioma	8.01e-05	0.000264	CbGpPWpGaD
Metixene—CHRM2—Signaling Pathways—CAV1—malignant glioma	7.99e-05	0.000263	CbGpPWpGaD
Metixene—CHRM3—Signaling Pathways—KDR—malignant glioma	7.98e-05	0.000263	CbGpPWpGaD
Metixene—CHRM2—Signaling Pathways—KDR—malignant glioma	7.9e-05	0.00026	CbGpPWpGaD
Metixene—HTR2C—Signaling Pathways—AKT2—malignant glioma	7.81e-05	0.000257	CbGpPWpGaD
Metixene—CHRM4—GPCR downstream signaling—AKT1—malignant glioma	7.78e-05	0.000256	CbGpPWpGaD
Metixene—HTR2C—Signaling by GPCR—EGFR—malignant glioma	7.78e-05	0.000256	CbGpPWpGaD
Metixene—CHRM3—Metabolism—PIK3CD—malignant glioma	7.73e-05	0.000254	CbGpPWpGaD
Metixene—CHRM5—Signaling Pathways—CXCL8—malignant glioma	7.71e-05	0.000254	CbGpPWpGaD
Metixene—CHRM4—Signaling Pathways—CASP3—malignant glioma	7.71e-05	0.000254	CbGpPWpGaD
Metixene—CHRM1—Signaling Pathways—FN1—malignant glioma	7.71e-05	0.000254	CbGpPWpGaD
Metixene—CHRM1—Signaling Pathways—F2—malignant glioma	7.71e-05	0.000254	CbGpPWpGaD
Metixene—CHRM4—Signaling Pathways—IL2—malignant glioma	7.7e-05	0.000253	CbGpPWpGaD
Metixene—CHRM3—Signaling Pathways—FN1—malignant glioma	7.68e-05	0.000253	CbGpPWpGaD
Metixene—CHRM3—Signaling Pathways—F2—malignant glioma	7.68e-05	0.000253	CbGpPWpGaD
Metixene—CHRM1—Signaling Pathways—BAD—malignant glioma	7.62e-05	0.000251	CbGpPWpGaD
Metixene—CHRM2—Signaling Pathways—F2—malignant glioma	7.61e-05	0.00025	CbGpPWpGaD
Metixene—CHRM2—Signaling Pathways—FN1—malignant glioma	7.61e-05	0.00025	CbGpPWpGaD
Metixene—CHRM3—Signaling Pathways—BAD—malignant glioma	7.59e-05	0.00025	CbGpPWpGaD
Metixene—CHRM1—Signaling Pathways—NOTCH1—malignant glioma	7.54e-05	0.000248	CbGpPWpGaD
Metixene—CHRM3—Signaling Pathways—NOTCH1—malignant glioma	7.52e-05	0.000247	CbGpPWpGaD
Metixene—CHRM2—Signaling Pathways—BAD—malignant glioma	7.52e-05	0.000247	CbGpPWpGaD
Metixene—HTR2C—Signaling Pathways—PIK3CD—malignant glioma	7.51e-05	0.000247	CbGpPWpGaD
Metixene—CHRM5—GPCR downstream signaling—AKT1—malignant glioma	7.45e-05	0.000245	CbGpPWpGaD
Metixene—CHRM2—Signaling Pathways—NOTCH1—malignant glioma	7.44e-05	0.000245	CbGpPWpGaD
Metixene—HTR2C—GPCR downstream signaling—PIK3CA—malignant glioma	7.44e-05	0.000245	CbGpPWpGaD
Metixene—CHRM1—Signaling Pathways—CD80—malignant glioma	7.39e-05	0.000243	CbGpPWpGaD
Metixene—CHRM5—Signaling Pathways—CASP3—malignant glioma	7.38e-05	0.000243	CbGpPWpGaD
Metixene—CHRM1—Signaling Pathways—PIK3CG—malignant glioma	7.38e-05	0.000243	CbGpPWpGaD
Metixene—CHRM1—Signaling Pathways—APC—malignant glioma	7.38e-05	0.000243	CbGpPWpGaD
Metixene—CHRM5—Signaling Pathways—IL2—malignant glioma	7.37e-05	0.000243	CbGpPWpGaD
Metixene—CHRM3—Signaling Pathways—CD80—malignant glioma	7.37e-05	0.000242	CbGpPWpGaD
Metixene—CHRM3—Signaling Pathways—PIK3CG—malignant glioma	7.35e-05	0.000242	CbGpPWpGaD
Metixene—CHRM3—Signaling Pathways—APC—malignant glioma	7.35e-05	0.000242	CbGpPWpGaD
Metixene—HTR2C—Signaling by GPCR—KRAS—malignant glioma	7.35e-05	0.000242	CbGpPWpGaD
Metixene—CHRM2—Signaling Pathways—CD80—malignant glioma	7.29e-05	0.00024	CbGpPWpGaD
Metixene—CHRM1—Signaling Pathways—EGF—malignant glioma	7.29e-05	0.00024	CbGpPWpGaD
Metixene—CHRM4—Signaling Pathways—MMP9—malignant glioma	7.28e-05	0.00024	CbGpPWpGaD
Metixene—CHRM2—Signaling Pathways—PIK3CG—malignant glioma	7.28e-05	0.00024	CbGpPWpGaD
Metixene—CHRM2—Signaling Pathways—APC—malignant glioma	7.28e-05	0.00024	CbGpPWpGaD
Metixene—CHRM3—Signaling Pathways—EGF—malignant glioma	7.27e-05	0.000239	CbGpPWpGaD
Metixene—CHRM1—Signaling Pathways—PTPN11—malignant glioma	7.25e-05	0.000239	CbGpPWpGaD
Metixene—CHRM4—Signaling Pathways—PTEN—malignant glioma	7.24e-05	0.000238	CbGpPWpGaD
Metixene—CHRM3—Signaling Pathways—PTPN11—malignant glioma	7.22e-05	0.000238	CbGpPWpGaD
Metixene—CHRM2—Signaling Pathways—EGF—malignant glioma	7.2e-05	0.000237	CbGpPWpGaD
Metixene—HTR2C—Signaling Pathways—FGF2—malignant glioma	7.19e-05	0.000237	CbGpPWpGaD
Metixene—CHRM2—Signaling Pathways—PTPN11—malignant glioma	7.15e-05	0.000235	CbGpPWpGaD
Metixene—CHRM4—Signaling by GPCR—AKT1—malignant glioma	7.07e-05	0.000233	CbGpPWpGaD
Metixene—CHRM5—Signaling Pathways—MMP9—malignant glioma	6.98e-05	0.00023	CbGpPWpGaD
Metixene—CHRM5—Signaling Pathways—PTEN—malignant glioma	6.94e-05	0.000228	CbGpPWpGaD
Metixene—CHRM1—Signaling Pathways—BRAF—malignant glioma	6.93e-05	0.000228	CbGpPWpGaD
Metixene—CHRM3—Signaling Pathways—BRAF—malignant glioma	6.91e-05	0.000227	CbGpPWpGaD
Metixene—CHRM2—Signaling Pathways—BRAF—malignant glioma	6.84e-05	0.000225	CbGpPWpGaD
Metixene—CHRM5—Signaling by GPCR—AKT1—malignant glioma	6.77e-05	0.000223	CbGpPWpGaD
Metixene—HTR2C—Signaling by GPCR—PIK3CA—malignant glioma	6.75e-05	0.000222	CbGpPWpGaD
Metixene—CHRM1—Signaling Pathways—AKT2—malignant glioma	6.75e-05	0.000222	CbGpPWpGaD
Metixene—CHRM3—Metabolism—PIK3CB—malignant glioma	6.74e-05	0.000222	CbGpPWpGaD
Metixene—CHRM3—Signaling Pathways—AKT2—malignant glioma	6.73e-05	0.000221	CbGpPWpGaD
Metixene—HTR2C—Signaling Pathways—MDM2—malignant glioma	6.72e-05	0.000221	CbGpPWpGaD
Metixene—CHRM1—Signaling by GPCR—EGFR—malignant glioma	6.72e-05	0.000221	CbGpPWpGaD
Metixene—HTR2C—Signaling Pathways—RAF1—malignant glioma	6.7e-05	0.000221	CbGpPWpGaD
Metixene—CHRM3—Signaling by GPCR—EGFR—malignant glioma	6.7e-05	0.000221	CbGpPWpGaD
Metixene—CHRM3—Metabolism—PTGS2—malignant glioma	6.68e-05	0.00022	CbGpPWpGaD
Metixene—CHRM2—Signaling Pathways—AKT2—malignant glioma	6.66e-05	0.000219	CbGpPWpGaD
Metixene—CHRM2—Signaling by GPCR—EGFR—malignant glioma	6.63e-05	0.000218	CbGpPWpGaD
Metixene—HTR2C—Signaling Pathways—ERBB2—malignant glioma	6.63e-05	0.000218	CbGpPWpGaD
Metixene—HTR2C—Signaling Pathways—PIK3CB—malignant glioma	6.54e-05	0.000215	CbGpPWpGaD
Metixene—CHRM4—Signaling Pathways—VEGFA—malignant glioma	6.54e-05	0.000215	CbGpPWpGaD
Metixene—CHRM1—Signaling Pathways—PIK3CD—malignant glioma	6.48e-05	0.000213	CbGpPWpGaD
Metixene—CHRM4—Signaling Pathways—STAT3—malignant glioma	6.48e-05	0.000213	CbGpPWpGaD
Metixene—CHRM3—Signaling Pathways—PIK3CD—malignant glioma	6.46e-05	0.000213	CbGpPWpGaD
Metixene—CHRM1—GPCR downstream signaling—PIK3CA—malignant glioma	6.42e-05	0.000211	CbGpPWpGaD
Metixene—CHRM3—GPCR downstream signaling—PIK3CA—malignant glioma	6.4e-05	0.000211	CbGpPWpGaD
Metixene—CHRM2—Signaling Pathways—PIK3CD—malignant glioma	6.4e-05	0.000211	CbGpPWpGaD
Metixene—CHRM1—Signaling by GPCR—KRAS—malignant glioma	6.35e-05	0.000209	CbGpPWpGaD
Metixene—CHRM2—GPCR downstream signaling—PIK3CA—malignant glioma	6.34e-05	0.000209	CbGpPWpGaD
Metixene—CHRM3—Signaling by GPCR—KRAS—malignant glioma	6.33e-05	0.000208	CbGpPWpGaD
Metixene—HTR2C—Signaling Pathways—CXCL8—malignant glioma	6.29e-05	0.000207	CbGpPWpGaD
Metixene—CHRM2—Signaling by GPCR—KRAS—malignant glioma	6.27e-05	0.000206	CbGpPWpGaD
Metixene—CHRM5—Signaling Pathways—VEGFA—malignant glioma	6.26e-05	0.000206	CbGpPWpGaD
Metixene—CHRM1—Signaling Pathways—FGF2—malignant glioma	6.21e-05	0.000204	CbGpPWpGaD
Metixene—CHRM5—Signaling Pathways—STAT3—malignant glioma	6.2e-05	0.000204	CbGpPWpGaD
Metixene—CHRM3—Signaling Pathways—FGF2—malignant glioma	6.19e-05	0.000204	CbGpPWpGaD
Metixene—CHRM2—Signaling Pathways—FGF2—malignant glioma	6.13e-05	0.000202	CbGpPWpGaD
Metixene—HTR2C—GPCR downstream signaling—AKT1—malignant glioma	6.07e-05	0.0002	CbGpPWpGaD
Metixene—CHRM4—Signaling Pathways—MYC—malignant glioma	6.02e-05	0.000198	CbGpPWpGaD
Metixene—HTR2C—Signaling Pathways—CASP3—malignant glioma	6.02e-05	0.000198	CbGpPWpGaD
Metixene—HTR2C—Signaling Pathways—IL2—malignant glioma	6.01e-05	0.000198	CbGpPWpGaD
Metixene—CHRM4—Signaling Pathways—EGFR—malignant glioma	5.89e-05	0.000194	CbGpPWpGaD
Metixene—CHRM1—Signaling by GPCR—PIK3CA—malignant glioma	5.83e-05	0.000192	CbGpPWpGaD
Metixene—CHRM3—Metabolism—PTEN—malignant glioma	5.82e-05	0.000192	CbGpPWpGaD
Metixene—CHRM3—Signaling by GPCR—PIK3CA—malignant glioma	5.81e-05	0.000191	CbGpPWpGaD
Metixene—CHRM1—Signaling Pathways—MDM2—malignant glioma	5.81e-05	0.000191	CbGpPWpGaD
Metixene—CHRM3—Signaling Pathways—MDM2—malignant glioma	5.79e-05	0.000191	CbGpPWpGaD
Metixene—CHRM1—Signaling Pathways—RAF1—malignant glioma	5.79e-05	0.000191	CbGpPWpGaD
Metixene—CHRM3—Signaling Pathways—RAF1—malignant glioma	5.77e-05	0.00019	CbGpPWpGaD
Metixene—CHRM5—Signaling Pathways—MYC—malignant glioma	5.76e-05	0.00019	CbGpPWpGaD
Metixene—CHRM2—Signaling by GPCR—PIK3CA—malignant glioma	5.76e-05	0.00019	CbGpPWpGaD
Metixene—CHRM2—Signaling Pathways—MDM2—malignant glioma	5.73e-05	0.000189	CbGpPWpGaD
Metixene—CHRM1—Signaling Pathways—ERBB2—malignant glioma	5.73e-05	0.000189	CbGpPWpGaD
Metixene—CHRM2—Signaling Pathways—RAF1—malignant glioma	5.71e-05	0.000188	CbGpPWpGaD
Metixene—CHRM3—Signaling Pathways—ERBB2—malignant glioma	5.71e-05	0.000188	CbGpPWpGaD
Metixene—HTR2C—Signaling Pathways—MMP9—malignant glioma	5.69e-05	0.000187	CbGpPWpGaD
Metixene—HTR2C—Signaling Pathways—PTEN—malignant glioma	5.65e-05	0.000186	CbGpPWpGaD
Metixene—CHRM2—Signaling Pathways—ERBB2—malignant glioma	5.65e-05	0.000186	CbGpPWpGaD
Metixene—CHRM1—Signaling Pathways—PIK3CB—malignant glioma	5.65e-05	0.000186	CbGpPWpGaD
Metixene—CHRM5—Signaling Pathways—EGFR—malignant glioma	5.64e-05	0.000186	CbGpPWpGaD
Metixene—CHRM3—Signaling Pathways—PIK3CB—malignant glioma	5.63e-05	0.000185	CbGpPWpGaD
Metixene—CHRM2—Signaling Pathways—PIK3CB—malignant glioma	5.58e-05	0.000184	CbGpPWpGaD
Metixene—CHRM4—Signaling Pathways—KRAS—malignant glioma	5.56e-05	0.000183	CbGpPWpGaD
Metixene—HTR2C—Signaling by GPCR—AKT1—malignant glioma	5.52e-05	0.000182	CbGpPWpGaD
Metixene—CHRM1—Signaling Pathways—CXCL8—malignant glioma	5.43e-05	0.000179	CbGpPWpGaD
Metixene—CHRM3—Signaling Pathways—CXCL8—malignant glioma	5.41e-05	0.000178	CbGpPWpGaD
Metixene—CHRM2—Signaling Pathways—CXCL8—malignant glioma	5.36e-05	0.000176	CbGpPWpGaD
Metixene—CHRM5—Signaling Pathways—KRAS—malignant glioma	5.33e-05	0.000175	CbGpPWpGaD
Metixene—CHRM1—GPCR downstream signaling—AKT1—malignant glioma	5.25e-05	0.000173	CbGpPWpGaD
Metixene—CHRM3—GPCR downstream signaling—AKT1—malignant glioma	5.23e-05	0.000172	CbGpPWpGaD
Metixene—CHRM1—Signaling Pathways—CASP3—malignant glioma	5.2e-05	0.000171	CbGpPWpGaD
Metixene—CHRM1—Signaling Pathways—IL2—malignant glioma	5.19e-05	0.000171	CbGpPWpGaD
Metixene—CHRM3—Signaling Pathways—CASP3—malignant glioma	5.18e-05	0.000171	CbGpPWpGaD
Metixene—CHRM2—GPCR downstream signaling—AKT1—malignant glioma	5.18e-05	0.00017	CbGpPWpGaD
Metixene—CHRM3—Signaling Pathways—IL2—malignant glioma	5.17e-05	0.00017	CbGpPWpGaD
Metixene—CHRM2—Signaling Pathways—CASP3—malignant glioma	5.13e-05	0.000169	CbGpPWpGaD
Metixene—CHRM2—Signaling Pathways—IL2—malignant glioma	5.12e-05	0.000169	CbGpPWpGaD
Metixene—CHRM4—Signaling Pathways—PIK3CA—malignant glioma	5.11e-05	0.000168	CbGpPWpGaD
Metixene—HTR2C—Signaling Pathways—VEGFA—malignant glioma	5.11e-05	0.000168	CbGpPWpGaD
Metixene—HTR2C—Signaling Pathways—STAT3—malignant glioma	5.06e-05	0.000166	CbGpPWpGaD
Metixene—CHRM4—Signaling Pathways—TP53—malignant glioma	4.94e-05	0.000163	CbGpPWpGaD
Metixene—CHRM1—Signaling Pathways—MMP9—malignant glioma	4.91e-05	0.000162	CbGpPWpGaD
Metixene—CHRM3—Signaling Pathways—MMP9—malignant glioma	4.9e-05	0.000161	CbGpPWpGaD
Metixene—CHRM5—Signaling Pathways—PIK3CA—malignant glioma	4.89e-05	0.000161	CbGpPWpGaD
Metixene—CHRM1—Signaling Pathways—PTEN—malignant glioma	4.88e-05	0.000161	CbGpPWpGaD
Metixene—CHRM3—Signaling Pathways—PTEN—malignant glioma	4.87e-05	0.00016	CbGpPWpGaD
Metixene—CHRM2—Signaling Pathways—MMP9—malignant glioma	4.85e-05	0.00016	CbGpPWpGaD
Metixene—CHRM2—Signaling Pathways—PTEN—malignant glioma	4.82e-05	0.000159	CbGpPWpGaD
Metixene—CHRM1—Signaling by GPCR—AKT1—malignant glioma	4.76e-05	0.000157	CbGpPWpGaD
Metixene—CHRM3—Signaling by GPCR—AKT1—malignant glioma	4.75e-05	0.000156	CbGpPWpGaD
Metixene—CHRM5—Signaling Pathways—TP53—malignant glioma	4.73e-05	0.000156	CbGpPWpGaD
Metixene—CHRM2—Signaling by GPCR—AKT1—malignant glioma	4.7e-05	0.000155	CbGpPWpGaD
Metixene—HTR2C—Signaling Pathways—MYC—malignant glioma	4.7e-05	0.000155	CbGpPWpGaD
Metixene—HTR2C—Signaling Pathways—EGFR—malignant glioma	4.6e-05	0.000151	CbGpPWpGaD
Metixene—CHRM1—Signaling Pathways—VEGFA—malignant glioma	4.41e-05	0.000145	CbGpPWpGaD
Metixene—CHRM3—Signaling Pathways—VEGFA—malignant glioma	4.4e-05	0.000145	CbGpPWpGaD
Metixene—CHRM1—Signaling Pathways—STAT3—malignant glioma	4.37e-05	0.000144	CbGpPWpGaD
Metixene—CHRM2—Signaling Pathways—VEGFA—malignant glioma	4.35e-05	0.000143	CbGpPWpGaD
Metixene—CHRM3—Signaling Pathways—STAT3—malignant glioma	4.35e-05	0.000143	CbGpPWpGaD
Metixene—HTR2C—Signaling Pathways—KRAS—malignant glioma	4.34e-05	0.000143	CbGpPWpGaD
Metixene—CHRM2—Signaling Pathways—STAT3—malignant glioma	4.31e-05	0.000142	CbGpPWpGaD
Metixene—CHRM4—Signaling Pathways—AKT1—malignant glioma	4.17e-05	0.000137	CbGpPWpGaD
Metixene—CHRM3—Metabolism—PIK3CA—malignant glioma	4.11e-05	0.000135	CbGpPWpGaD
Metixene—CHRM1—Signaling Pathways—MYC—malignant glioma	4.06e-05	0.000134	CbGpPWpGaD
Metixene—CHRM3—Signaling Pathways—MYC—malignant glioma	4.05e-05	0.000133	CbGpPWpGaD
Metixene—CHRM2—Signaling Pathways—MYC—malignant glioma	4.01e-05	0.000132	CbGpPWpGaD
Metixene—CHRM5—Signaling Pathways—AKT1—malignant glioma	4e-05	0.000132	CbGpPWpGaD
Metixene—HTR2C—Signaling Pathways—PIK3CA—malignant glioma	3.99e-05	0.000131	CbGpPWpGaD
Metixene—CHRM1—Signaling Pathways—EGFR—malignant glioma	3.97e-05	0.000131	CbGpPWpGaD
Metixene—CHRM3—Signaling Pathways—EGFR—malignant glioma	3.96e-05	0.00013	CbGpPWpGaD
Metixene—CHRM2—Signaling Pathways—EGFR—malignant glioma	3.92e-05	0.000129	CbGpPWpGaD
Metixene—HTR2C—Signaling Pathways—TP53—malignant glioma	3.86e-05	0.000127	CbGpPWpGaD
Metixene—CHRM1—Signaling Pathways—KRAS—malignant glioma	3.75e-05	0.000123	CbGpPWpGaD
Metixene—CHRM3—Signaling Pathways—KRAS—malignant glioma	3.74e-05	0.000123	CbGpPWpGaD
Metixene—CHRM2—Signaling Pathways—KRAS—malignant glioma	3.7e-05	0.000122	CbGpPWpGaD
Metixene—CHRM1—Signaling Pathways—PIK3CA—malignant glioma	3.45e-05	0.000113	CbGpPWpGaD
Metixene—CHRM3—Signaling Pathways—PIK3CA—malignant glioma	3.43e-05	0.000113	CbGpPWpGaD
Metixene—CHRM2—Signaling Pathways—PIK3CA—malignant glioma	3.4e-05	0.000112	CbGpPWpGaD
Metixene—CHRM3—Metabolism—AKT1—malignant glioma	3.36e-05	0.00011	CbGpPWpGaD
Metixene—CHRM1—Signaling Pathways—TP53—malignant glioma	3.33e-05	0.00011	CbGpPWpGaD
Metixene—CHRM3—Signaling Pathways—TP53—malignant glioma	3.32e-05	0.000109	CbGpPWpGaD
Metixene—CHRM2—Signaling Pathways—TP53—malignant glioma	3.29e-05	0.000108	CbGpPWpGaD
Metixene—HTR2C—Signaling Pathways—AKT1—malignant glioma	3.26e-05	0.000107	CbGpPWpGaD
Metixene—CHRM1—Signaling Pathways—AKT1—malignant glioma	2.81e-05	9.27e-05	CbGpPWpGaD
Metixene—CHRM3—Signaling Pathways—AKT1—malignant glioma	2.81e-05	9.24e-05	CbGpPWpGaD
Metixene—CHRM2—Signaling Pathways—AKT1—malignant glioma	2.78e-05	9.15e-05	CbGpPWpGaD
